Local Institution - 0041 — Kennewick, Washington

Local Institution - 0041 is a clinical research site located in Kennewick, Washington, United States 99336.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Local Institution - 0041 has participated in 1 clinical trials.

Therapeutic areas: Non-Squamous Cell Non-small Cell Lung Cancer.

Sponsors: Bristol-Myers Squibb.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Kennewick

Browse all research sites in Washington · View every site in Kennewick

• Kadlec Clinic Hematology and Oncology
• Columbia Basin Hematology
• Northwest Cancer Clinic
• Columbia Basin Hematology and Oncology
• Columbia Basin Hematology and Oncology PLLC
• Tri-Cities Cancer Center
• Research Site
• Pfizer Investigational Site
• Columbia Basin Hematology & Oncology
• GSK Investigational Site
• Kadlec Clinic Hematology and Oncology Kadlec Clinic Hematology & Onc
• Kadlec Clinic Rheumatology

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution - 0041?

Local Institution - 0041 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution - 0041 conducted?

Local Institution - 0041 has 1 clinical trials on record. Their work covers Non-Squamous Cell Non-small Cell Lung Cancer.

Is Local Institution - 0041 accredited by Crixeo Clinical Trials?

Local Institution - 0041 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Local Institution - 0041?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.